Percutaneous Coronary Intervention (PCI)
Title: Percutaneous Coronary Intervention (PCI)Category: Procedures and TestsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 1/3/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - January 3, 2020 Category: Cardiology Source Type: news
Welcome Data Show Two Sides of PCI in Patients With Cancer Welcome Data Show Two Sides of PCI in Patients With Cancer
Although more patients with cancer are living longer and are undergoing percutaneous coronary intervention, data are scarce on contemporary stent performance.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - December 31, 2019 Category: Surgery Tags: Cardiology News Source Type: news
University Hospital Giessen Performs First Minimally Invasive, Robotic-Assisted Coronary Intervention in Germany
The University Hospital Giessen is the first hospital in Germany where a robotic system assists in a minimally invasive procedure to place a stent into a narrowed coronary artery to reopen it. This percutaneous coronary intervention (PCI) was carried out by the team of Prof. Holger Nef, Deputy Clinical Director Medical Clinic I, Cardiology and Angiology, University Giessen. (Source: eHealth News EU)
Source: eHealth News EU - December 18, 2019 Category: Information Technology Tags: Featured Siemens Healthineers Business and Industry Source Type: news
Can 3D Modeling Replace a Guidewire-Based Cardiac Procedure?
The CathWorks FFRangio System, which received FDA clearance in late last year, has just been approved by the Japan's Ministry of Health, Labour and Welfare (MHLW). Designed for use during angiography, the non-invasive diagnostic tool turns routine angiogram images into color-coded 3D renderings of blood flow in the heart's arteries. Physicians can then use the images to determine whether a stent is needed.
“The CathWorks FFRangio System automatically receives the angiograms in DiCOM format from the C-ARM (X-Ray) systems at the time of angiogram procedure,†Ramin Mousavi, vice president,&...
Source: MDDI - December 17, 2019 Category: Medical Devices Authors: Daphne Allen Tags: Cardiovascular Source Type: news
Many Patients Overestimate the Benefits of PCI
MONDAY, Dec. 9, 2019 -- Many patients do not understand or remember the information given to them during the informed consent process for percutaneous coronary intervention (PCI), according to a study published online Nov. 27 in the European Journal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 9, 2019 Category: Pharmaceuticals Source Type: news
AHA: Impella Use Up for PCI Patients Needing Heart Pump
THURSDAY, Nov. 21, 2019 -- Impella use is increasing for percutaneous coronary intervention (PCI) patients treated with mechanical circulatory support (MCS), although its use is associated with adverse events, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 21, 2019 Category: Pharmaceuticals Source Type: news
PCI, CABG for Left Main CAD Have Similar Five-Year Outcomes
FRIDAY, Oct. 4, 2019 -- Five-year rates of a composite outcome of death, stroke, and myocardial infarction are similar for patients with left main coronary artery disease following either percutaneous coronary intervention (PCI) or coronary artery... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 4, 2019 Category: Pharmaceuticals Source Type: news
Less Bleeding With Ticagrelor Alone in High-Risk Patients
FRIDAY, Sept. 27, 2019 -- Ticagrelor alone results in less bleeding than ticagrelor plus aspirin among high-risk patients who have undergone percutaneous coronary intervention (PCI) and received dual antiplatelet therapy for three months, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 27, 2019 Category: Pharmaceuticals Source Type: news
First & #039;Artificial Meniscus & #039; Wins FDA Breakthrough Device Designation
U.S. patients who continue to suffer from knee pain after meniscus surgery, but are too young for total knee replacement may soon have a new treatment option. FDA has granted Active Implants' NUsurface meniscus implant a breakthrough device designation.
The artificial meniscus device is already available in Europe and, if cleared by FDA, would also be the first artificial meniscus in the United States.Â
Earlier this year Active Implants gained some attention from Needham & Co.'s Mike Matson, who included the company on a list of interesting private medtech companies.&Acir...
Source: MDDI - September 19, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Orthopedics Source Type: news
Short DAPT After DES: P2Y12 Monotherapy in, Aspirin out! Short DAPT After DES: P2Y12 Monotherapy in, Aspirin out!
A new study addresses the question of when aspirin can be safely discontinued in higher risk patients such as those undergoing complex percutaneous coronary intervention.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 18, 2019 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Expert Alert: Study finds repeat coronary artery bypass grafting improves long-term survival
ROCHESTER, Minn. ?-- When a coronary artery bypass grafting (CABG) patient needs a second surgery because of recurrent chest pain, more often than not it's a percutaneous coronary intervention (PCI), commonly known as coronary angioplasty with stents. A study published in September in Mayo Clinic Proceedings says that a better option may be repeating the [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 17, 2019 Category: Databases & Libraries Source Type: news
Shockwave Gets a Little Pep in Its Step with Breakthrough Device Designation
The regulatory pathway for Shockwave Medical’s Intravascular Lithotripsy (IVL) technology just received a huge jolt from FDA. The agency granted the Santa Clara, CA-based company breakthrough device designation for the Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter.
The firm’s device is designed to fracture problematic calcium using sonic pressure to facilitate stent delivery, deployment, and optimal expansion, thereby improving blood flow to the heart muscle.
Shockwave’s technology is being evaluated in the DISRUPT CAD III, a prospective, non-randomiz...
Source: MDDI - September 4, 2019 Category: Medical Devices Authors: Omar Ford Tags: Regulatory and Compliance Cardiovascular Source Type: news
In STEMI, Biodegradable Polymer Sirolimus-Eluting Stents Superior
TUESDAY, Sept. 3, 2019 -- For patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI), there were fewer target lesion failures at one year in those receiving biodegradable polymer... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 3, 2019 Category: Pharmaceuticals Source Type: news
Complete Revascularization Best for STEMI With Multivessel CAD
TUESDAY, Sept. 3, 2019 -- For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease, complete revascularization is superior to culprit lesion-only percutaneous coronary intervention (PCI), according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 3, 2019 Category: Pharmaceuticals Source Type: news
Early after routine heart procedures, other operations become riskier
(Reuters Health) - Patients who have so-called percutaneous coronary intervention (PCI) procedures to restore blood flow to the heart may be more likely to have complications with non-cardiac surgery than other people, a U.S. study suggests. (Source: Reuters: Health)
Source: Reuters: Health - August 30, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
